General Announcement::GPL announces grant of substitution and successful launch of generic Seretide Accuhaler in Denmark

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
16-May-2018 11:17:59
Status
New
Announcement Sub Title
GPL announces grant of substitution and successful launch of generic Seretide Accuhaler in Denmark
Announcement Reference
SG180516OTHRQQ40
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
16/05/2018 09:00:00
Description (Please provide a detailed description of the event in the box below)
Glenmark announces grant of substitution and successful launch of generic Seretide Accuhaler in Denmark.

Attachments

PR_16052018.pdf
Total size =3295K